What sizes are available for Interleukin-4 IL4 Rabbit Polyclonal Antibody (Carrier-free)?

Interleukin-4 IL4 Rabbit Polyclonal Antibody (Carrier-free) is available in the following size(s): 100 µg.

Interleukin-4 IL4 Rabbit Polyclonal Antibody (Carrier-free)

Q: What is the catalog number for Interleukin-4 IL4 Rabbit Polyclonal Antibody (Carrier-free)?

The catalog number for Interleukin-4 IL4 Rabbit Polyclonal Antibody (Carrier-free) is orb3082745.

Anti-Interleukin-4 IL4 Antibody. Tested in WB applications. This antibody reacts with Mouse. The brand indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as , ensuring unmatched performance.

Product Specifications

Product Name Alternative

B cell stimulatory factor 1; Binetrakin; BSF 1; BSF1; IL 4; IL4; IL-4; interleukin 4; Pitrakinra

UniProt

P07750

Reactivity

Mouse

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

A synthetic peptide corresponding to a sequence at the C-terminus of mouse IL-4.

Target

Interleukin-4

Clonality

Polyclonal

Conjugation

Carrier-free

Field of Research

Cancer Biology, Immunology & Inflammation

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Mouse

Form

Lyophilized

Molecular Weight

37 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.